ArticleCureus2025
Functional Outcomes After Injections of Platelet-Rich Plasma for Plantar Fasciitis.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Biological Mechanisms and Clinical Challenges of Platelet-Rich Plasma in Chronic Musculoskeletal Pain: From Standardized Preparation to Multi-Omics-Guided Precision Therapy.Journal of pain research · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective Plantar fasciitis is a rather common disorder with symptoms like heel discomfort. It usually gets worse with prolonged rest. Platelet-rich plasma (PRP) injections, derived from autologous blood, have emerged as a promising treatment option by promoting tissue healing and reducing inflammation. This study evaluates the outcome of PRP injections in decreasing pain and improving patients' function. Methods This study included 100 identified cases of plantar fasciitis altogether. After PRP injections, their results were evaluated using the American Orthopedic Foot and Ankle Score (AOFAS) at baseline and the visual analog scale (VAS) both at baseline and four, eight, and 12 weeks following injection. Results The mean VAS decreased to one from seven in males and from seven to one in females. A statistically significant difference existed between the males and females at four weeks (p ≤ 0.0001), eight weeks (p ≤ 0.0001), and 12 weeks (p = 1.0), and the AOFAS score reached 95/96 from 56/58 in males and females. Conclusion The efficacy of PRP in the treatment of plantar fasciitis is very high. It provides very good outcomes with significant pain relief while also promoting healing of the plantar fascia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.